Drug susceptibility of low growing non-tuberculous mycobacteria
https://doi.org/10.21292/2075-1230-2016-94-4-43-50
Abstract
In order to investigate the spectrum of drug susceptibility of slowly growing of non-tuberculous mycobacteria and define minimum inhibiting concentrations (MIC) regarding the drug panel including anti-tuberculosis drugs and antimicrobial agents of wide spectrum, 68 strains of slow growing non-tuberculous mycobacteria belonging to such species as M. avium, M. intracellulare, M. gordonae, M. kansasii, M. xenopi, M. malmoense and M. simiae were tested. Minimum inhibiting concentrations were defined with use of the panel consisting of 13 drugs of SLOWMYCO Sensititre (Trek Diagnostic System, Thermo Scientific, USA). It has been proved that the majority of tested strains of non-tuberculous mycobacteria were susceptible to clarithromycin and rifabutin. Amikacin, linezolid and moxifloxacin were also fairly effective. Considering that for mycobacteria of M. avium the borderline drug concentrations were not defined it is important to investigate and to compare the results of defining minimum inhibiting concentrations in vitro with therapy efficiency.
About the Authors
S. N. Аndreevskaya
Central Tuberculosis Research Institute
Russian Federation
Russian Federation
Candidate of Medical Sciences, Senior Researcher of Microbiological Department,
2, Yauzskaya Alleya, Moscow, 107564
E. E. Larionova
Central Tuberculosis Research Institute
Russian Federation
Russian Federation
Candidate of Biological Sciences, Senior Researcher,
2, Yauzskaya Alleya, Moscow, 107564
T. G. Smirnova
Central Tuberculosis Research Institute
Russian Federation
Russian Federation
Candidate of Medical Sciences, Senior Researcher,
2, Yauzskaya Alleya, Moscow, 107564
I. Yu. Аndrievskaya
Central Tuberculosis Research Institute
Russian Federation
Russian Federation
Junior Researcher,
2, Yauzskaya Alleya, Moscow, 107564
E. A. Kiseleva
Central Tuberculosis Research Institute
Russian Federation
Russian Federation
Laboratory Researcher,
2, Yauzskaya Alleya, Moscow, 107564
L. N. Chernousova
Central Tuberculosis Research Institute
Russian Federation
Russian Federation
Doctor of Biological Sciences, Professor, Head of Microbiological Department,
2, Yauzskaya Alleya, Moscow, 107564
References
1. Klinicheskie rekomendatsii Opredelenie chuvstvitelnosti mikroorganizmov k antimikrobnym preparatam. [Clinical recommendations on susceptibility testing of microorganisms to antimicrobial agents]. Mezhregionalnaya Assotsiatsiya po Klinicheskoy Mikrobiologii i Antimikrobnoy Khimioterapii Publ., 2014, 154 p.
2. Litvinov V.I., Makarova N.V., Krasnova M.А. Netuberkulyoznye mikobakterii. [Non-tuberculous mycobacteria]. Moscow, MNPTsBT Publ., 2008, 256 p. (In Russ.)
3. Mayorova A.A. Identifikatsiya netuberkuleznykh mikobakteriy i vybor optimal’noy kombinatsii metodov dlya ikh vidovoy differentsiatsii. Diss. Kand. Biol. Nauk. [Identification of non-tuberculous mycobacteria and choice of the best combination of techniques for spieces idemtification. Cand. Diss.]. Moscow, 2007, 26 p.
4. Makarova M.V., Krasnova M.А., Khachaturiants E.N. Susceptibility of non-tuberculous mycobacteria to drugs. Tub., 2011, no. 6, pp. 51-55. (In Russ.)
5. Makarova M.V., Freyman G.E. Anti-tuberculosis drugs susceptibility studying of non-tuberculous mycobacteria isolated on solid and liquid nutritive media. Tub., 2009, no. 8, pp. 49-51. (In Russ.)
6. Otten T.F., Vasiliev А.V. Mikobaketerioz. [Mycobacteriosis.] St. Petersburg, Meditsinskaya Pressa Publ., 2005, 224 p.
7. Edict no. 951 by RF MoH as of 29.19.2014 On Approval of Guidelines for Improvement of Respiratory Tuberculosis Diagnostics and Treatment. 44 p. (In Russ.)
8. Chernousova L.N. Sovremennaya mikrobiologicheskaya diagnostika TB. [Modern microbiological diagnostics of tuberculosis]. Мединар. https://www.youtube.com/watch?v= qLT1hr2HSzY
9. Chernousova L.N., Sevastianova E.V., Larionova E.E. et al. Federal’nye klinicheskie rekomendatsii po organizatsii i provedeniyu mikrobiologicheskoy i molekulyarno-geneticheskoy diagnostiki tuberkuleza. [Federal clinical recommendations in organisation and implementation of microbiological and molecular-genetic diagnostics of tuberculosis]. Tver, OOO Izdatelstvo Triada Publ., 2015, 46 p.
10. Arend S.M., van Soolingen D., Ottenhoff T.H. Diagnosis and treatment of lung infection with nontuberculous mycobacteria. Curr. Opin. Pulm. Med., 2009, vol. 15, no. 3, pp. 201-208.
11. Cassidy P.M., Hedberg K., Saulson A. et al. Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin. Infect. Dis., 2009, vol. 49, pp. e124-e129.
12. Clinical and Laboratory Standards Institute. Susceptibility testing of mycobacteria, nocardia, and other aerobic actinomycetes; approved Standard, M24-A2. Wayne, PA: CLSI. 2011, 76 p.
13. Daley C.L., Griffith D.E. Pulmonary non-tuberculous mycobacterial infections. Int. J. Tuberc. Lung. Dis., 2010, vol. 14, no. 6, pp. 665-671.
14. Falkinham J.O. 3rd Epidemiology of infection by nontuberculous mycobacteria. Clin. Microbiol. Rev., 1996, vol. 9, no. 2, pp. 177-215.
15. Falkinham J.O. 3rd Surrounded by mycobacteria: nontuberculous mycobacteria in the human environment. J. Appl. Microbiol., 2009, vol. 107, pp. 356-367.
16. Field S.K., Fisher D., Cowie R.L. Mycobacterium avium complex pulmonary disease in patient without HIV infection. Chest, 2004, vol. 126, no. 2, pp. 566-581.
17. Griffith D.E., Aksamit T., Brown-Elliott B.A. et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med., 2007, vol. 175, no. 4, pp. 367-416.
18. Hoefsloot W., van Ingen J., Andrejak C. et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: a NTM-NET collaborative study. Eur. Respir. J., 2013, vol. 42, no. 6, pp. 1604-1613.
19. Li G., Lian L.L., Wan L. et al. Antimicrobial susceptibility of standard strains
20. of nontuberculous mycobacteria by microplate Alamar Blue assay. PLoS One, 2013, vol. 8, no. 12, pp. e84065.
21. Martin-Casabona N., Bahrmand A.R., Bennedsen J. et al. Nontuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. Int. J. Tuberc. Lung. Dis., 2004, vol. 8, pp. 1186-1193.
22. Mirsaeidi M., Farshidpour M., Ebrahimi G. et al. Management of nontuberculous mycobacterial infection in the elderly. Eur. J. Intern. Med., 2014, vol. 25, no. 4, pp. 356-363.
23. Mirsaeidi M., Machado R.F., Garcia J.G. et al. Nontuberculous mycobacterial disease mortality in the United States, 1999-2010: a population-based comparative study. PLoS One, 2014, vol. 9, no. 3, pp. e91879.
24. Padoveze M.C., Fortaleza C.M., Freire M.P. et al. Outbreak of surgical infection caused by non-tuberculous mycobacteria in breast implants in Brazil. J. Hosp. Infect., 2007, vol. 67, no. 2, pp. 161-167.
25. Philley J.V., Griffith D.E. Treatment of Slowly Growing Mycobacteria. Clin. Chest Med., 2015, vol. 36, no. 1, pp. 79-90.
26. Richter E., Rüsch-Gerdes S., Hillemann D. Evaluation of the GenoType Mycobacterium Assay for identification of mycobacterial species from cultures. J. Clin. Microbiol., 2006, vol. 44, no. 5, pp. 1769-1775.
27. Said H.M., Ismail N., Osman A. et al. Evaluation of TBc identification immunochromatographic assay for rapid identification of Mycobacterium tuberculosis complex in samples from broth cultures. J. Clin. Microbiol., 2011, vol. 49, no. 5, pp. 1939-1942.
28. Tabarsi P., Baghaei P., Farnia P. et al. Nontuberculous mycobacteria among patients who are suspected for multidrug-resistant tuberculosis need for earlier identify cation of nontuberculous mycobacteria. Am.J. Med., Sci. 2009, vol. 337, no. 3, pp. 182-184.
29. van der Werf M.J., Ködmön C., Katalinić-Janković V. et al. Inventory study of non-tuberculous mycobacteria in the European Union. BMC Infect Dis., 2014, vol. 6, pp. 14-62.
30. van Ingen J., Bendien S.A., de Lange W.C. et al. Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands. Thorax, 2009, vol. 64, no. 6, pp. 502-506.
Review
For citations:
Аndreevskaya S.N., Larionova E.E., Smirnova T.G., Аndrievskaya I.Yu., Kiseleva E.A., Chernousova L.N. Drug susceptibility of low growing non-tuberculous mycobacteria. Tuberculosis and Lung Diseases. 2016;94(4):43-50. (In Russ.) https://doi.org/10.21292/2075-1230-2016-94-4-43-50
Views:
1559
Email this article 